Clinical Trials on Type 2 Diabetes in Canada

Total 4700 results

University of Alberta

Completed

Fasted Exercise Training in Type 2 Diabetes (FED)

Diabetes Mellitus, Type 2

Canada
University of Alberta

Completed

Pre-operative Carbohydrate Loading Patients With Diabetes Undergoing Elective Colorectal Surgery

Diabetes Mellitus, Type 2

Canada
Dr. Danièle Pacaud
The Lawson Foundation

Completed

The Clinical and Economic Impacts of e-Heath on Diabetes (eHealthDM)

Diabetes Mellitus, Type 2

Canada
Unity Health Toronto
University Health Network, Toronto; St. Joseph's Health Centre Toronto

Unknown

Lifestyle Intervention For Effective Diabetes Management (LIFE-DM)

Diabetes Mellitus, Type 2

Canada
Bristol-Myers Squibb
Merck Sharp & Dohme LLC

Completed

Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
Montreal Heart Institute
Institut de Recherches Cliniques de Montreal

Recruiting

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes (APPEASED)

Diabetes Mellitus, Type 2

Canada
McGill University

Completed

A Study to Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 Diabetes

Diabetes Mellitus, Type 2

Canada
Novo Nordisk A/S

Completed

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice (SURE CANADA)

Diabetes Mellitus, Type 2

Canada
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Australia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
Medicure

Completed

MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)

Hypertension | Metabolic Syndrome | Diabetes Mellitus Type 2

Canada
Sanofi

Completed

Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients (TITRATION)

Type 2 Diabetes Mellitus

Canada
Mount Sinai Hospital, Canada
Novo Nordisk A/S

Completed

Blood Pressure Outcomes With Liraglutide Therapy (BOLT)

Type 2 Diabetes | Systolic Hypertension

Canada
Bayer
LMC Diabetes & Endocrinology

Completed

Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D) (AWARE-CKD)

Renal Insufficiency, Chronic

Canada
Sanofi

Completed

Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients

Diabetes Mellitus, Type 2

United States, Canada
Ottawa Hospital Research Institute

Completed

Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients. (SAS)

Hypertension | Diabetic Nephropathy | Type 2 Diabetes | Sleep Apnea

Canada
Centre hospitalier de l'Université de Montréal...
Radiological Society of North America; Centre de Recherche du Centre Hospitalier... and other collaborators

Completed

Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes (LIRAINS)

Type 2 Diabetes | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis

Canada
Galenicum Health

Completed

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers

Type 2 Diabetes | Bioequivalence

Canada
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period (LixiLan-G)

Type 2 Diabetes Mellitus

Estonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
University of Victoria
The Lawson Foundation

Completed

The Role and Effectiveness of Diabetes Coaches in British Columbia

Diabetes Mellitus, Type 2

Canada
AstraZeneca
Bristol-Myers Squibb

Completed

Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Canada, Mexico, India, Puerto Rico, Russian Federation, South Africa
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Type 2 Diabetes Mellitus

United States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
Bayer

Completed

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN)

Diabetic Nephropathies

Hong Kong, Australia, Spain, Portugal, United States, France, Canada, Netherlands, Austria, Finland, Poland, Taiwan, Hungary, Israel, Italy, South Africa, Sweden, Bulgaria, Germany, Denmark, Czechia, Korea, Republic of, Norway
Laval University

Completed

Portable Monitoring Device, Physical Activity Motivation and Patients With Type 2 Diabetes (DBFitbit)

Diabetes Mellitus, Type 2 | Physical Activity | Motivation

Canada
Unity Health Toronto

Completed

The Effect of Viscous Fiber on Glycemic Control in Individuals With Diabetes (VF&GC)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Canada
The Canadian College of Naturopathic Medicine

Unknown

Integrative Care for Type 2 Diabetes

Diabetes Mellitus, Type 2

Canada
University of Victoria
Vancouver Foundation

Completed

The Effectiveness of Diabetes Patient Education and Self-Management Education in Persons With Type 2 Diabetes

Diabetes Mellitus, Type 2

Canada
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)

Type 2 Diabetes Mellitus

Russian Federation, United States, Puerto Rico, Australia, Taiwan, Israel, Spain, Canada, Greece, Argentina, Poland, Romania, Mexico, Slovakia, Brazil
Sanofi

Completed

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine (GetGoal-Duo1)

Type 2 Diabetes Mellitus

United States, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, South Africa, Swed... and more
Theracos

Completed

Bexagliflozin Efficacy and Safety Trial (BEST)

Type 2 Diabetes Mellitus

United States, Canada, Czechia, Denmark, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Taiwan
Montreal Heart Institute

Recruiting

Home-based Heat Therapy for Type 2 Diabetes

Diabetes Mellitus, Type 2 | Heat Exposure

Canada
University of Guelph

Completed

Vitamin D and Omega-3 Inhibit Metabolic Syndrome

Hypertension | Obesity | Type 2 Diabetes Mellitus | Hyperlipidemia

Canada
Ionis Pharmaceuticals, Inc.

Completed

Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes

Type 2 Diabetes Mellitus

Canada, Romania, South Africa
Sanofi

Completed

Self Titration With Apidra to Reach Target Study (START)

Diabetes Mellitus, Type 2

Canada
Bristol-Myers Squibb

Completed

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

South Africa, United States, Canada, Puerto Rico, Hungary, Germany, Czechia, Poland, Romania, United Kingdom
McMaster University
Canadian Institutes of Health Research (CIHR); Ontario Ministry of Health and...

Completed

Comparison Study of Usual Care vs. Usual Care Plus Community Intervention to Manage Type 2 Diabetes

Type 2 Diabetes Mellitus | NIDDM | Non-insulin Dependent Diabetes Mellitus

Canada
Western University, Canada
St. Joseph's Health Care London

Completed

Reducing Sedentary Behaviour in Patients With Type II Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Sedentary Lifestyle

Canada
Sanofi

Completed

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM) (LixilanOne CAN)

Type 2 Diabetes Mellitus

Canada
University of Calgary
Canadian Institutes of Health Research (CIHR); Alberta Health services; Alberta... and other collaborators

Recruiting

Healthy Food Prescription Incentive Program

Diabetes Mellitus, Type 2 | Diabetes Complications | Diet, Healthy

Canada
Bristol-Myers Squibb

Completed

Safety Study of BMS-770767 in Subjects With Type 2 Diabetes

Diabetes Type 2

United States, Canada, Korea, Republic of, Australia
Sanofi

Completed

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications (SENIOR)

Type 2 Diabetes Mellitus

United States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular Events

Myocardial Infarction | Heart Failure | Ischemic Stroke | Type2 Diabetes | Cardiovascular Death | All-Cause Mortality

Canada
Eli Lilly and Company
Locemia Solutions ULC

Terminated

A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Canada
Eli Lilly and Company
Locemia Solutions ULC

Completed

A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Canada
University Health Network, Toronto

Recruiting

Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients (INFINITI2019)

Type 2 Diabetes | Kidney Transplant Recipients | Post-transplant Diabetes Mellitus

Canada
Endocrine Research Society

Terminated

3-Month Trial Observation of A1c Change

Type 2 Diabetes

Canada
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes (SURPASS-3)

Type 2 Diabetes Mellitus

United States, Korea, Republic of, Taiwan, Italy, Austria, Puerto Rico, Hungary, Greece, Poland, Spain, Romania, Ukraine, Argentina
University of British Columbia
Novo Nordisk A/S

Terminated

The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without Diabetes

Type 2 Diabetes | Peripheral Vascular Disease

Canada
McMaster University
Dairy Farmers of Canada

Completed

Be Healthy in Pregnancy (B-HIP): A Trial to Study Nutrition and Exercise Approaches for Healthy Pregnancy (BHIP)

Obesity | Type 2 Diabetes | Weight Gain | Excessive Weight Gain in Pregnancy as Antepartum Condition

Canada
Sanofi

Completed

Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)

Type 2 Diabetes Mellitus

France, Russian Federation, United States, Argentina, Canada, Germany, South Africa, Italy, Netherlands, United Kingdom, Australia, Chile
AstraZeneca
Bristol-Myers Squibb

Completed

Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea

Type 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c Level

Czech Republic, Poland, Spain, Germany, Canada, Slovakia

Clinical Trials on Type 2 Diabetes in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations